StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)

Close on Nov 17, 2026Market cap $94.88MP/E –Yield –

NovaBridge Biosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

NovaBridge Biosciences's pe ratio was 22.6× on Feb 28, 2022, against 55.5× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Feb 28, 202222.6×−21.2
2021Dec 31, 202143.8×–

More NovaBridge Biosciences figures

See a number that looks wrong?